Thickness of functionalized graphene oxide sheets plays critical role in tissue accumulation and urinary excretion: A pilot PET/CT study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Novoselov, 2011, Nobel lecture: graphene: materials in the flatland*, Rev. Mod. Phys., 83, 837, 10.1103/RevModPhys.83.837
Bitounis, 2013, Prospects and challenges of graphene in biomedical applications, Adv. Mater., 25, 2258, 10.1002/adma.201203700
Pan, 2012, The application of graphene oxide in drug delivery, Expert Opin. Drug Deliv., 9, 1365, 10.1517/17425247.2012.729575
Krishna, 2013, Graphene-based nanomaterials for nanobiotechnology and biomedical applications, Nanomedicine, 8, 1669, 10.2217/nnm.13.140
Loh, 2010, Graphene oxide as a chemically tunable platform for optical applications, Nat. Chem., 2, 1015, 10.1038/nchem.907
Feng, 2011, Graphene in biomedicine: opportunities and challenges, Nanomedicine, 6, 317, 10.2217/nnm.10.158
Ferrari, 2006, Raman spectrum of graphene and graphene layers, Phys. Rev. Lett., 97, 187401, 10.1103/PhysRevLett.97.187401
Bendali, 2013, Purified neurons can survive on peptide-Free graphene layers, Adv. Healthcare Mater., 2, 929, 10.1002/adhm.201200347
Liu, 2012, Biological and chemical sensors based on graphene materials, Chem. Soc. Rev., 41, 2283, 10.1039/C1CS15270J
Servant, 2014, Graphene-based electroresponsive scaffolds as polymeric implants for on-demand drug delivery, Adv. Healthcare Mater., 3, 1334, 10.1002/adhm.201400016
Kostarelos, 2014, Exploring the interface of graphene and biology, Science, 344, 261, 10.1126/science.1246736
Liu, 2012, Effect of size and dose on the biodistribution of graphene oxide in mice, Nanomedicine, 7, 1801, 10.2217/nnm.12.60
Liu, 2015, Biocompatibility of graphene oxide intravenously administrated in mice-effects of dose, size and exposure protocols, Toxicol. Res., 4, 83, 10.1039/C4TX00044G
Zhang, 2011, Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration, Carbon, 49, 986, 10.1016/j.carbon.2010.11.005
Qu, 2013, The ex vivo and in vivo biological performances of graphene oxide and the impact of surfactant on graphene oxide’s biocompatibility, J. Environ. Sci., 25, 873, 10.1016/S1001-0742(12)60252-6
Ali-Boucetta, 2013, Purified graphene oxide dispersions lack in vitro cytotoxicity and in vivo pathogenicity, Adv. Healthcare Mater., 2, 433, 10.1002/adhm.201200248
Yang, 2013, In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration, Biomaterials, 34, 2787, 10.1016/j.biomaterials.2013.01.001
Yan, 2012, Can graphene oxide cause damage to eyesight?, Chem. Res. Toxicol., 25, 1265, 10.1021/tx300129f
Schinwald, 2011, Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties, ACS Nano, 6, 736, 10.1021/nn204229f
Yang, 2011, In vivo pharmacokinetics long-term biodistribution, and toxicology of PEGylated graphene in mice, ACS Nano, 5, 516, 10.1021/nn1024303
Yang, 2010, Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy, Nano Lett., 10, 3318, 10.1021/nl100996u
Zhang, 2011, In vitro and in vivo behaviors of dextran functionalized graphene, Carbon, 49, 4040, 10.1016/j.carbon.2011.05.056
Jasim, 2015, Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets, Chem. Sci., 6, 3952, 10.1039/C5SC00114E
Duch, 2011, Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung, Nano Lett., 11, 5201, 10.1021/nl202515a
Ma-Hock, 2013, Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black, Part. Fibre Toxicol., 10, 23, 10.1186/1743-8977-10-23
Bussy, 2015, The current graphene safety landscape—a literature mining exercise, Nanoscale, 7, 6432, 10.1039/C5NR00236B
Murdock, 2013, Controlling the orientation edge geometry, and thickness of chemical vapor deposition graphene, ACS Nano, 7, 1351, 10.1021/nn3049297
Jasim, 2016, Synthesis of few-layered, high-purity graphene oxide sheets from different graphite sources for biology, 2D Mater., 3, 014006, 10.1088/2053-1583/3/1/014006
Sosabowski, 2006, Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes, Nat. Protoc., 1, 972, 10.1038/nprot.2006.175
Boutin, 2015, 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke, Eur. J. Nucl. Med. Mol. Imaging, 42, 503, 10.1007/s00259-014-2939-8
Kaiser, 1970, Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides, Anal. Biochem., 34, 595, 10.1016/0003-2697(70)90146-6
Wick, 2014, Classification framework for graphene-based materials, Angew. Chem. Int. Ed., 23, 7714, 10.1002/anie.201403335
Li, 2013, Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene, Small, 10, 1544, 10.1002/smll.201303234
Ferrari, 2007, Raman spectroscopy of graphene and graphite: disorder, electron–phonon coupling, doping and nonadiabatic effects, Solid State Commun., 143, 47, 10.1016/j.ssc.2007.03.052
Kim, 2012, Room-temperature metastability of multilayer graphene oxide films, Nat. Mater., 11, 544, 10.1038/nmat3316
Zhou, 2013, Origin of the chemical and kinetic stability of graphene oxide, Sci. Rep., 3, 2484, 10.1038/srep02484
Longmire, 2008, Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats, Nanomedicine, 3, 703, 10.2217/17435889.3.5.703
Liu, 2013, Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology, Mater. Today, 16, 477, 10.1016/j.mattod.2013.11.003
Yu, 2015, Clearance pathways and tumor targeting of imaging nanoparticles, ACS Nano, 9, 6655, 10.1021/acsnano.5b01320
Lacerda, 2008, Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion, Adv. Mater., 20, 225, 10.1002/adma.200702334
Choi, 2010, Design considerations for tumour-targeted nanoparticles, Nat. Nanotechnol., 5, 42, 10.1038/nnano.2009.314
Zhang, 2012, In vivo renal clearance, biodistribution, toxicity of gold nanoclusters, Biomaterials, 33, 4628, 10.1016/j.biomaterials.2012.03.020
Zhou, 2011, Luminescent gold nanoparticles with efficient renal clearance, Angew. Chem. Int. Ed., 50, 3168, 10.1002/anie.201007321
Hong, 2006, Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers, J. Am. Chem. Soc., 128, 1078, 10.1021/ja056726i
Burns, 2009, Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine, Nano Lett., 9, 442, 10.1021/nl803405h
Zhou, 2013, Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging, ACS Nano, 7, 3287, 10.1021/nn305991e
Huang, 2013, Effect of injection routes on the biodistribution clearance, and tumor uptake of carbon dots, ACS Nano, 7, 5684, 10.1021/nn401911k
Yang, 2015, Renal clearance and degradation of glutathione-Coated copper nanoparticles, Bioconjugate Chem., 26, 511, 10.1021/acs.bioconjchem.5b00003
Tang, 2014, Sub-10nm Pd nanosheets with renal clearance for efficient near-infrared photothermal cancer therapy, Small, 10, 3139, 10.1002/smll.201303631
Ruggiero, 2010, Paradoxical glomerular filtration of carbon nanotubes, Proc. Natl. Acad. Sci., 107, 12369, 10.1073/pnas.0913667107
Russier, 2013, Evidencing a mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells, Nanoscale, 5, 11234, 10.1039/c3nr03543c